Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Hematological Oncology|February 14, 2008
Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working PartyFelicetto Ferrara, Paola Fazi, Adriano Venditti, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
Detection of the t(11;14)(q13;q32) without CCND1/IGH fusion in a case of acute myeloid leukemiaMarina Tarsitano, Salvatore Palmieri, Felicetto Ferrara, et al.
Hematological Oncology|February 12, 2009
Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphanFelicetto Ferrara, Salvatore Palmieri, Mariangela Pedata, et al.
Haematologica|May 16, 2002
Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantationFranco Leoni, Giacomo Gianfaldoni, Mario Annunziata, et al.
Thrombosis Research|March 5, 2011
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndromePaul R J Ames, Maurizio Margaglione, Antonio Ciampa, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Frontiers in Oncology|August 4, 2022
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?Massimo Bernardi, Felicetto Ferrara, Matteo Giovanni Carrabba, et al.
Annals of Hematology|January 20, 2004
Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two casesFelicetto Ferrara, Carmine Selleri, Giuseppina Mele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfanFelicetto Ferrara, Tiziana Izzo, Clelia Criscuolo, et al.
Hematological Oncology|September 17, 2011
Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basisFelicetto Ferrara, Tiziana Izzo, Clelia Criscuolo, et al.
Pageof 15